This is not a procurement notice or a request for proposals, but a request for information to potential suppliers.

This notice is an invitation to market dialogue aimed at mapping the solution options available from suppliers operating in the market as well as their price estimates. The information and responses provided in this request for information do not bind the provider. Only the information in an offer submitted as a result of a potential request for proposals will bind the supplier. This notice does not obligate the contracting authority to carry out the procurement. The contracting authority will not compensate for any costs incurred from participating in the market dialogue.
The responses received will be treated confidentially. Respondents are requested to indicate any possible trade secret information contained in their responses, which will be treated confidentially. The publicity of information and documents submitted to the authorities is governed by the Act on the Publicity of Government Activities (21.5.1999/621).

The Varsinais-Suomi welfare area is mapping the market situation of high-capacity NGS/parallel sequencing devices used in patient diagnostics for DNA and RNA-based sequencing studies.

The sequencer will be used for the diagnostic testing of hereditary and somatic DNA and RNA samples, covering whole exome and whole genome-wide studies. The sequencer to be procured must be able to run libraries using short read technology as well as distance mapping technology (providing information from longer genomic regions). The libraries to be sequenced must be able to use samples extracted using current DNA extraction methods available in the laboratory. The sequencer must function as a backup device to the sequencers already in the laboratory without extensive validation. The device must be flexible in capacity so that routine diagnostics can sequence both smaller sample batches (up to 12 samples) and larger whole genome sample batches (at least 48 samples) as needed.

The absolute requirements for the device are as follows:
1. The device must serve as a backup device for the instruments currently in use in the laboratory, meaning its sequencing chemistry must correspond to that already used in the laboratory.
2. The device must also include an option for automated library preparation, sequencing, and bioinformatics as a package, enabling long haploblocks and the analysis of pseudogene regions with gene-specific algorithms.
3. The libraries to be sequenced must be able to use samples extracted with current methods available in the laboratory.
4. The device's capacity must be flexible in such a way that it can accommodate at least four size classes of run cassettes according to the size of the sample batches. We request that you include in your response a brochure of the proposed device as well as your preliminary, non-binding price estimate for the proposed device/solution.

We request that you include a brochure of the device you propose in your response along with your preliminary, non-binding price estimate for the proposed device/solution. You may also attach brochures with your response.

LOT-0000
Request for Information: High Capacity NGS/Parallel Sequencing Device.
This is not a procurement notice or a request for proposals, but a request for information to potential suppliers.

This notice is an invitation to market dialogue aimed at mapping the solution options available from suppliers operating in the market as well as their price estimates. The information and responses provided in this request for information do not bind the provider. Only the information in an offer submitted as a result of a potential request for proposals will bind the supplier. This notice does not obligate the contracting authority to carry out the procurement. The contracting authority will not compensate for any costs incurred from participating in the market dialogue.
The responses received will be treated confidentially. Respondents are requested to indicate any possible trade secret information contained in their responses, which will be treated confidentially. The publicity of information and documents submitted to the authorities is governed by the Act on the Publicity of Government Activities (21.5.1999/621).

The Varsinais-Suomi welfare area is mapping the market situation of high-capacity NGS/parallel sequencing devices used in patient diagnostics for DNA and RNA-based sequencing studies.

The sequencer will be used for the diagnostic testing of hereditary and somatic DNA and RNA samples, covering whole exome and whole genome-wide studies. The sequencer to be procured must be able to run libraries using short read technology as well as distance mapping technology (providing information from longer genomic regions). The libraries to be sequenced must be able to use samples extracted using current DNA extraction methods available in the laboratory. The sequencer must function as a backup device to the sequencers already in the laboratory without extensive validation. The device must be flexible in capacity so that routine diagnostics can sequence both smaller sample batches (up to 12 samples) and larger whole genome sample batches (at least 48 samples) as needed.

The absolute requirements for the device are as follows:
1. The device must serve as a backup device for the instruments currently in use in the laboratory, meaning its sequencing chemistry must correspond to that already used in the laboratory.
2. The device must also include an option for automated library preparation, sequencing, and bioinformatics as a package, enabling long haploblocks and the analysis of pseudogene regions with gene-specific algorithms.
3. The libraries to be sequenced must be able to use samples extracted with current methods available in the laboratory.
4. The device's capacity must be flexible in such a way that it can accommodate at least four size classes of run cassettes according to the size of the sample batches. We request that you include in your response a brochure of the proposed device as well as your preliminary, non-binding price estimate for the proposed device/solution.

We request that you include a brochure of the device you propose in your response along with your preliminary, non-binding price estimate for the proposed device/solution. You may also attach brochures with your response.